PPARD

Peroxisome Proliferator-Activated Receptor Delta

Gene Information Card

Symbol PPARD
Full Name Peroxisome Proliferator-Activated Receptor Delta
Gene Type protein-coding
Chromosomal Location 6p21.31
NCBI Gene ID 5467 ncbi.nlm.nih.gov/gene/5467
Ensembl ID ENSG00000112033
UniProt ID Q03181
OMIM ID 600409
HGNC ID 9235
Aliases PPARB, NR1C2, NUC1, FAAR

Description

PPARD encodes peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates lipid metabolism, glucose homeostasis, inflammation, and cell proliferation. It binds to peroxisome proliferator response elements (PPREs) and modulates transcription of target genes involved in fatty acid oxidation, energy expenditure, and insulin sensitivity. PPARD is implicated in metabolic disorders, cardiovascular disease, and cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Metabolic Syndrome PPARD activation improves insulin sensitivity and lipid metabolism; variants may alter risk PMID: 19037247
Colorectal Cancer PPARD overexpression promotes cell proliferation and tumor growth via β-catenin/TCF signaling PMID: 21575862
Cardiovascular Disease PPARD regulates lipid metabolism and inflammation in vascular endothelium; polymorphisms associated with dyslipidemia PMID: 20628086
Obesity PPARD variants influence body mass index and energy expenditure PMID: 16959974

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 5.8 Low
Skeletal Muscle 12.3 Medium
Heart 15.1 Medium
Adipose Tissue 8.2 Low
Colon 20.4 High
Small Intestine 18.7 High
Kidney 6.5 Low
Brain 3.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 4.5 Hepatocellular carcinoma cell line
Caco-2 22.1 Colorectal adenocarcinoma cell line
MCF7 7.8 Breast cancer cell line
A549 9.3 Lung carcinoma cell line
HT-29 19.6 Colorectal adenocarcinoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.280C>T (p.Arg94Trp) Missense <0.01% Altered ligand binding; reduced transcriptional activity
c.494A>G (p.Asn165Ser) Missense <0.01% Unknown functional effect
c.842C>T (p.Pro281Leu) Missense <0.01% Impaired heterodimerization with RXR
c.1165G>A (p.Val389Met) Missense <0.01% Reduced PPRE binding
Mutation functional classification

Loss of Function (LOF)

Mutations such as p.Arg94Trp and p.Pro281Leu reduce ligand binding or heterodimerization, impairing transcriptional activation.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported in PPARD.

Dominant Negative (DN)

No dominant-negative mutations described for PPARD.

Pathways

• PPAR signaling pathway (KEGG: hsa03320)
• Adipocytokine signaling pathway (KEGG: hsa04920)
• AMPK signaling pathway (KEGG: hsa04152)
• Insulin signaling pathway (KEGG: hsa04910)
• Fatty acid metabolism (Reactome: R-HSA-8978868)

Protein Summary

PPARD is a 441-amino acid nuclear receptor with a conserved DNA-binding domain and ligand-binding domain. It forms heterodimers with retinoid X receptors (RXRs) and binds to PPREs in target gene promoters. PPARD regulates genes involved in fatty acid oxidation, energy uncoupling, and glucose transport. It is activated by endogenous fatty acids and synthetic ligands such as GW501516. PPARD plays roles in metabolic adaptation, wound healing, and cancer progression.

Related Products

Product name Cat.No. Species Gene ID
Ppard Knockout NIT-1 Cell Line EDJ-KQ60 Mouse 19015 Details Get a Quote
PPARD Knockout HEK293 Cell Line EDJ-KQ115 Human 5467 Details Get a Quote
PPARD Knockout A-549 Cell Line EDJ-KQ18475 Human 5467 Details Get a Quote
PPARD Knockout HCT 116 Cell Line EDJ-KQ18476 Human 5467 Details Get a Quote
PPARD Knockout HeLa Cell Line EDJ-KQ18477 Human 5467 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: